home / stock / argnf / argnf quote
Last: | $383.74 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $383.74 |
High: | $0 |
Low: | $0 |
Volume: | 136 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$383.74 | $0 | $383.74 | $0 | $0 | 136 | 04-18-2024 |
$383.74 | $0 | $383.74 | $0 | $0 | 48 | 03-22-2024 |
$383.74 | $383.74 | $383.74 | $383.74 | $383.74 | 100 | 03-21-2024 |
$391.775 | $391.775 | $391.775 | $391.775 | $391.775 | 1 | 02-15-2024 |
$365.68 | $365.6 | $365.68 | $365.68 | $365.6 | 16 | 02-14-2024 |
$361.93 | $0 | $361.93 | $0 | $0 | 280 | 02-09-2024 |
$361.93 | $361.93 | $361.93 | $361.93 | $361.93 | 1 | 01-11-2024 |
$371 | $0 | $371 | $0 | $0 | 97 | 01-08-2024 |
$371 | $371 | $371 | $371 | $371 | 19 | 12-25-2023 |
$371 | $371 | $371 | $371 | $371 | 19 | 12-22-2023 |
$341 | $428.6 | $341 | $428.6 | $341 | 3 | 12-20-2023 |
$505 | $0 | $505 | $0 | $0 | 97 | 12-12-2023 |
$505 | $505 | $505 | $505 | $505 | 5 | 11-10-2023 |
$503.175 | $503.175 | $503.175 | $503.175 | $503.175 | 28 | 10-12-2023 |
$453.05 | $453.05 | $453.05 | $453.05 | $453.05 | 1 | 10-03-2023 |
$384 | $0 | $384 | $0 | $0 | 20 | 09-27-2023 |
$384 | $0 | $384 | $0 | $0 | 32 | 08-23-2023 |
$384 | $384 | $384 | $384 | $384 | 1 | 07-10-2023 |
$397.9 | $0 | $397.9 | $0 | $0 | 260 | 07-06-2023 |
$397.9 | $0 | $397.9 | $0 | $0 | 24,000 | 06-21-2023 |
News, Short Squeeze, Breakout and More Instantly...
Argen X NV Company Name:
ARGNF Stock Symbol:
OTCMKTS Market:
ADHERE data show VYVGART ® Hytrulo has potential to be first advancement for CIDP patients in 30 years Real-world data demonstrate gMG patients able to significantly reduce steroid use over first six months of initiating VYVGART ® treatment April 16, 2024...
RHO study supports proof-of-concept in primary Sjogren’s disease Decision informed by favorable safety profile and consistency across efficacy and biomarker measures March 27, 2024, 7:00 AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ...
March 26, 2024 Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that the Annual General Meeting of shareholders will be held at 1...